Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2002-9-30
pubmed:abstractText
Prostaglandins (PGs) having antitumor activity such as delta12,14-PGJ2, delta12-PGJ2, PGA2 and PGA1 strongly inhibited topoisomerase II (topo II) from human placenta, the potential order of inhibitory activity of the PGs resembling that of the antitumor activity. PGs having no antitumor activity did not inhibit topo II. Delta12,14-PGJ2 to be a potent inhibitor showed inhibitions to some extent against topo I from wheat germ, NIH3T3 and calf thymus gland, and showed no inhibition against the enzymes from Vero, A549, HeLa and COLO 201 cells. Delta12,14-PGJ2 differentially inhibited topo I from different sources. Delta12,14-PGJ2 was a topo inhibitor of the cleavable complex-nonforming type without DNA intercalation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/9-deoxy-delta-9-prostaglandin D2, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin, http://linkedlifedata.com/resource/pubmed/chemical/DNA, Superhelical, http://linkedlifedata.com/resource/pubmed/chemical/DNA Topoisomerases, Type I, http://linkedlifedata.com/resource/pubmed/chemical/DNA Topoisomerases, Type II, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Ethidium, http://linkedlifedata.com/resource/pubmed/chemical/Etoposide, http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandin D2, http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandins, http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandins A, http://linkedlifedata.com/resource/pubmed/chemical/Topoisomerase I Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Topoisomerase II Inhibitors
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0916-8451
pubmed:author
pubmed:issnType
Print
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1706-12
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:12353631-Animals, pubmed-meshheading:12353631-Antineoplastic Agents, pubmed-meshheading:12353631-Camptothecin, pubmed-meshheading:12353631-DNA, Superhelical, pubmed-meshheading:12353631-DNA Topoisomerases, Type I, pubmed-meshheading:12353631-DNA Topoisomerases, Type II, pubmed-meshheading:12353631-Doxorubicin, pubmed-meshheading:12353631-Enzyme Inhibitors, pubmed-meshheading:12353631-Ethidium, pubmed-meshheading:12353631-Etoposide, pubmed-meshheading:12353631-Humans, pubmed-meshheading:12353631-Mice, pubmed-meshheading:12353631-Prostaglandin D2, pubmed-meshheading:12353631-Prostaglandins, pubmed-meshheading:12353631-Prostaglandins A, pubmed-meshheading:12353631-Topoisomerase I Inhibitors, pubmed-meshheading:12353631-Topoisomerase II Inhibitors, pubmed-meshheading:12353631-Tumor Cells, Cultured
pubmed:year
2002
pubmed:articleTitle
Inhibitory properties of antitumor prostaglandins against topoisomerases.
pubmed:affiliation
Laboratory of Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, Kumamoto University, Japan.
pubmed:publicationType
Journal Article